Drug: Placebo Placebo comparator, every 2 weeks, subcutaneous. All-cause death was defined as the death due to any cause during the course of study.
For general information, Learn About Clinical Studies. Talk with your doctor and family members or friends about deciding to a study. Cardiovascular death amrboise defined as sudden cardiac death, fatal MI, death due to heart failure, death due to stroke fatal ischemic stroke or fatal stroke of undetermined etiologyor death due to other cardiovascular causes.
Major CV event was defined as any of the following: CV death defined as sudden cardiac death, fatal myocardial infarction [MI], death due to heart failure, death due to stroke [fatal ischemic stroke or fatal stroke of undetermined etiology], or death due to other cardiovascular causes non-fatal MI, non-fatal stroke, and hospitalization for unstable angina needing urgent revascularization. To learn more about this study, you or your doctor may contact the study research staff using fcuk contacts provided below.
Other Name: RN Placebo comparator, every 2 weeks, subcutaneous. The duration of the treatment period will depend upon bbuddies the targeted of adjudicated and confirmed CV outcome events, approximately 3 to 4 years after the entry of first subject into the study.
Event rate was calculated as the of events per participant-years at risk.